33
/es/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512560
319423
2
Public Timelines
FAQ Obtener premium

1 ene 2011 año - Ipilimumab

Descripción:

For the diagnosis of inoperable or metastatic melanoma, the Food and Drug Administration (FDA) permits the use of ipilimumab, a monoclonal antibody. Ipilimumab stimulates the immune system by removing a "brake" that normally controls the intensity of immune responses to attack cancer cells.

Añadido al timeline:

14 nov 2019
0
0
302

fecha:

1 ene 2011 año
Ahora mismo
~ 14 years ago